A liquid biopsy is a blood test designed to detect cancer cells or DNA fragments of cancer cells circulating in the ...

A new "liquid biopsy" test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, while helping some avoid further tests and treatments, including chemotherapy.

A proof of concept study suggests an FT-IR microspectroscopy blood test can detect a single circulating tumour cell in a lung cancer patient, supporting future real time monitoring.

England's health system said it will roll out new cancer testing known as liquid biopsy, first to 15,000 lung cancer patients, then to many others. Experts say the technology is revolutionary because ...

The US Food and Drug Administration (FDA) today approved the first blood-based genetic test that can detect epidermal growth factor receptor (EGFR) gene mutations in non-small cell lung cancer ...

Liquid biopsies analyze materials like circulating tumor DNA (ctDNA) in the blood to provide a non-invasive look at a cancer’s genetic profile. They are highly effective for tracking tumor evolution, ...

“Lung cancer is a disease where uncontrolled cell growth occurs in the lung leading to tumours,” explains Dr Jenny Messenger, consultant in respiratory and general medicine at Nuffield Health Brighton ...

Lung cancer screening can detect cancer early when it’s most treatable. See if you qualify for a low-dose CT scan at Fred Hutch.

Detailed price information for Biomark Diagnostics Inc (BMKDF) from The Globe and Mail including charting and trades.

UK researchers have developed an infrared-based blood test that can detect a single circulating lung cancer cell. Using FT-IR ...